Merus Labs International Inc. (MSL)

Merus Labs International Inc. (MSL $1.65)
- View MSL Profile
- View Questions on MSL

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Merus Labs International Inc. (MSL $1.65)
- View MSL Profile
- View Questions on MSL

Q: It appears the $1.65/share takeover by Norgine is set for Sept 30, 2017. Between now an then do you see any other upside above $1.65? I read at Pharmpro.com, 'The Arrangement Agreement includes a non-solicitation covenant on the part of Merus, subject to customary "fiduciary out" provisions that entitle Merus to consider and accept unsolicited superior proposals and a right in favour of Norgine to match any superior proposal....'

Read Answer Asked by Gordon on May 11, 2017

Gold Springs Resource Corp. (GRC $0.10)
- $0.10 Cap: $26M
- View GRC Profile
- View Questions on GRC
Merus Labs International Inc. (MSL $1.65)
- View MSL Profile
- View Questions on MSL
Cipher Pharmaceuticals Inc. (CPH $12.72)
- $12.72 P/E (TTM): 25.05X Cap: $316M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH

Q: All three of these companies were once market darlings that have fallen from their more favorable market days and are now attempting turnarounds. Do any of these companies appear to be a turnaround buy at their current levels? If not,and if they sit in one's portfolio, should they be ejected? if so, how would they rate from worst (eject 1st)to best (still hope, eject last).
Thanks!

Read Answer Asked by WAYNE on May 09, 2017

Photon Control Inc. (PHO $3.60)
- $3.60 P/E (TTM): 30.31X Cap: $376M
- View PHO Profile
- View Questions on PHO
- View Reports on PHO
Merus Labs International Inc. (MSL $1.65)
- View MSL Profile
- View Questions on MSL
Cipher Pharmaceuticals Inc. (CPH $12.72)
- $12.72 P/E (TTM): 25.05X Cap: $316M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Sandvine Corporation (SVC $4.39)
- $4.39 P/E (TTM): 47.7X
- View SVC Profile
- View Questions on SVC

Q: I currently have 1/2 positions in MSL,CPH and SVC. MSL and CPH look like dead money with not a lot of growth potential going forward. SVC looks okay. I'm looking to enter a full position with PHO using proceeds from the sale of MSL and CPH (I would keep SVC for now and monitor). For heath care representation in my portfolio, I have a full position in GUD already (thanks 5i)! For a growth oriented portfolio, will this be a good move 3-5 years out? What do you consider an attractive entry point for PHO?

Thanks!

Read Answer Asked by WAYNE on April 20, 2017